Founder & CEO · Hemab Therapeutics · Cambridge, Massachusetts, United States
Fresh capital means vendor and tool decisions are happening right now.
Open roles signal budget is being allocated across the org.
Most founders lock in key vendors within 60 days of closing a round.
Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
